Current status: 1092 hESC lines, 7212 hiPSC lines, and 182 clinical studies, and 2394 certificates
Monthly statistic from Jul 1, 2025
Posted on July 1, 2025
total lines | 8304 |
hESC lines | 1092 |
hiPSC lines | 7212 |
derivation countries | 50 |
projects | 323 |
providers | 992 |
clinical studies | 182 |
subclones | 3616 |
certificates | 2394 |
cell line certificates | 2244 |
project certificates | 150 |